ur US product development efforts are key to the expansion of Merz’ product portfolio. We focus primarily on product licensing and acquisition to support our growing specialty pharmaceutical franchise.

Merz’ German-based research efforts include development of pharmaceutical products for the treatment of central nervous system (CNS) disorders as well as over-the-counter products for the prevention of illness and preservation of well-being.